Abstract:Endothelial cell activation plays a critical role in leukocyte recruitment during inflammation and infection. We previously found that cholinergic stimulation (via vagus nerve stimulation) attenuates vascular endothelial impairment and reduces the inflammatory profile in ovariectomized rats. However, the specific molecular mechanism is unclear. This study was designed to explore the effects and molecular mechanisms of cholinergic agonists (acetylcholine [ACh]) on lipopolysaccharide (LPS)-induced endothelial cell activation in vitro. Human umbilical vein endothelial cells (HUVECs) were treated with different concentrations of LPS (10/100/1000 ng/mL) to activate endothelial cells. HUVECs were untreated, treated with ACh (10−5 M) alone, treated with 100 ng/mL LPS alone, or treated with different concentrations of ACh (10−9/10−8/10−7/10−6/10−5 M) before LPS stimulation. HUVECs were also pre-treated with 10−6 M ACh with or without mecamylamine (an nAChR blocker) (10 µM) and methyllycaconitine (a specific α7 nAChR blocker) (10 µM) and incubated with or without LPS. ELISA, western blotting, cell immunofluorescence, and cell adhesion assays were used to examine inflammatory cytokine production, adhesion molecule expression, monocyte-endothelial cell adhesion and activation of the MAPK/NF-κB pathways. LPS (at 10 ng/mL, 100 ng/mL and 1,000 ng/mL) increased VCAM-1 expression in HUVECs in a dose-dependent manner (with no significant difference between LPS at 100 ng/mL and 1,000 ng/mL). ACh (10−9 M–10−5 M) blocked adhesion molecule expression (VCAM-1, ICAM-1, and E-selectin) and inflammatory cytokine production (TNF-α, IL-6, MCP-1, IL-8) in response to LPS in a dose-dependent manner (with no significant difference between 10−5 and 10−6 M Ach). LPS was also shown to significantly enhance monocyte-endothelial cell adhesion, which was largely abrogated by treatment with ACh (10−6 M). VCAM-1 expression was blocked by mecamylamine rather than methyllycaconitine. Lastly, ACh (10−6 M) significantly reduced LPS-induced phosphorylation of NF-κB/p65, IκBα, ERK, JNK and p38 MAPK in HUVECs, which was blocked by mecamylamine. ACh protects against LPS-induced endothelial cell activation by inhibiting the MAPK and NF-κB pathways, which are mediated by nAChR, rather than α7 nAChR. Our results may provide novel insight into the anti-inflammatory effects and mechanisms of ACh.

Lysophosphatidylcholine Promotes Trained Immunity of Human Aortic Endothelial Cells Via Histone 3 Lysine 14 Acetylation‐dependent and Independent Gene Modulation

Increased Acetylation of H3K14 in the Genomic Regions That Encode Trained Immunity Enzymes in Lysophosphatidylcholine-Activated Human Aortic Endothelial Cells – Novel Qualification Markers for Chronic Disease Risk Factors and Conditional DAMPs

Lysophospholipids Induce Innate Immune Transdifferentiation of Endothelial Cells, Resulting in Prolonged Endothelial Activation

Inhibition of Polycomb Repressor Complex 2 Ameliorates Neointimal Hyperplasia by Suppressing Trimethylation of H3K27 in Vascular Smooth Muscle Cells.

Downregulation of activating transcription factor 4 attenuates lysophosphatidycholine-induced inflammation via the NF-κB pathway.

Novel Knowledge-Based Transcriptomic Profiling of Lipid Lysophosphatidylinositol-Induced Endothelial Cell Activation

Abstract 211: IL-35 Suppresses Endothelial Cell Activation by Inhibiting Histone H3K14 Acetylation and AP-1

Lipopolysaccharide activated phosphatidylcholine-specific phospholipase C and induced IL-8 and MCP-1 production in vascular endothelial cells.

Abstract 029: Interleukin-35 Suppresses Endothelial Activation by Inhibiting Mitochondrial Reactive Oxygen Species Mediated Site-specific Acetylation of Histone 3 Lysine 14

Phosphorylcholine-Primed Dendritic Cells Aggravate the Development of Atherosclerosis in ApoE-/- Mice.

Acetylcholine Suppresses LPS-induced Endothelial Cell Activation by Inhibiting the MAPK and NF-κB Pathways.

BAS/BSCR26 Histone Deacetylase 3 Protects Endothelial Cells from Inflammation Via Regulation of Galectin 9 Expression

Acetylation licenses Th1 cell polarization to constrain Listeria monocytogenes infection

Anti-inflammatory cytokines IL-35 and IL-10 block atherogenic lysophosphatidylcholine-induced, mitochondrial ROS-mediated innate immune activation, but spare innate immune memory signature in endothelial cells.

Effects of Lysophosphatidylcholine on Monolayer Cell Permeability of Human Coronary Artery Endothelial Cells

Activation of ICAM-1 promoter by lysophosphatidylcholine: possible involvement of protein tyrosine kinases.

By activating endothelium histone H4 mediates oleic acid-induced acute respiratory distress syndrome

Mir‐34a Targets HDAC1‐Regulated H3K9 Acetylation on Lipid Accumulation Induced by Homocysteine in Foam Cells

Abstract 17378: Atheroprotective Laminar Flow Represses the H3k27me3 Epigenetic Mark in Human Endothelial Cells Through Down-regulation of Ezh2

Dynamic changes in chromatin accessibility are associated with the atherogenic transitioning of vascular smooth muscle cells

Histone Deacetylase Regulation of MAP Kinase Phosphatase-1 Acetylation and Inflammation (135.36)